Cargando…

Survival-associated alternative splicing signatures in soft tissue sarcomas

Detalles Bibliográficos
Autores principales:	Ren, Xianghai, Jiang, Qi, Li, Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154430/ https://www.ncbi.nlm.nih.gov/pubmed/32309298 http://dx.doi.org/10.21037/atm.2020.01.113

Ejemplares similares

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Identification of prognostic alternative splicing events in sarcoma
por: Li, Hongshuai, et al.
Publicado: (2021)

Soft Tissue Sarcoma: New Paradigms in Care
por: Choong, Peter
Publicado: (2012)

Treatment Strategies for Metastatic Soft Tissue Sarcomas
por: Wiltink, Lisette M., et al.
Publicado: (2021)

Survival-associated alternative splicing signatures in non-small cell lung cancer
por: Zhao, Deze, et al.
Publicado: (2020)

Prognostic factors for survival in soft tissue sarcoma.
por: el-Jabbour, J. N., et al.
Publicado: (1990)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Thyroid Carcinoma
por: Han, Baoai, et al.
Publicado: (2021)

Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas
por: Yang, Xia, et al.
Publicado: (2019)

Mediastinal soft tissue sarcoma: dark sides and future lights
por: Palmieri, Giovannella, et al.
Publicado: (2020)

A Novel Four-Gene Prognostic Signature for Prediction of Survival in Patients with Soft Tissue Sarcoma
por: Wu, Changwu, et al.
Publicado: (2021)

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Epidemiology, pathological characteristics and survival of retroperitoneal soft‑tissue sarcomas compared with non‑retroperitoneal soft tissue sarcomas
por: Buja, Alessandra, et al.
Publicado: (2023)

Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas
por: Lin, Peng, et al.
Publicado: (2018)

Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature
por: He, Rong-quan, et al.
Publicado: (2017)

Development of a radiosensitivity gene signature for patients with soft tissue sarcoma
por: Tang, Zaixiang, et al.
Publicado: (2017)

Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2021)

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
por: Bertucci, Francois, et al.
Publicado: (2022)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

Soft tissue sarcomas: introduction to the Virchows Archiv review issue
por: Guillou, Louis, et al.
Publicado: (2010)

Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data
por: Xu, Ning, et al.
Publicado: (2020)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis
por: Lawlor, Rita T., et al.
Publicado: (2019)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma
por: Spraker, Matthew B., et al.
Publicado: (2019)

Definitive Local Therapy Is Associated with Improved Survival in Metastatic Soft Tissue Sarcomas
por: Reddy, Vishruth K., et al.
Publicado: (2021)

Sarcopenia Does Not Affect Survival or Outcomes in Soft-Tissue Sarcoma
por: Wilson, Robert J., et al.
Publicado: (2015)

Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma
por: Hoven-Gondrie, Miriam L., et al.
Publicado: (2016)

Nanomaterial Technology and Soft Tissue Sarcomas
por: Zhou, Changkai, et al.
Publicado: (2022)

Multidisciplinary Management of Soft Tissue Sarcoma
por: Nystrom, Lukas M., et al.
Publicado: (2013)

Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning
por: Qi, Lin, et al.
Publicado: (2023)

Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
por: Hahnel, Antje, et al.
Publicado: (2012)

Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas
por: Judge, Sean J., et al.
Publicado: (2022)

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
por: Nielsen, O. S., et al.
Publicado: (1998)

Novel nomograms individually predict the survival of patients with soft tissue sarcomas after surgery
por: Zhang, Shi-Long, et al.
Publicado: (2019)

Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
por: Shen, Rui, et al.
Publicado: (2021)

A novel inflammatory signature for evaluating immune microenvironment status in soft tissue sarcoma
por: Li, Zhehong, et al.
Publicado: (2022)

Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature
por: Tang, Zaixiang, et al.
Publicado: (2017)

How should orthopaedic oncologists prevent unplanned resections of soft tissue sarcomas by general practitioners?
por: Mochizuki, Kazuo
Publicado: (2012)

Myxoid liposarcoma: a well-defined clinical target variant in radiotherapy for soft tissue sarcoma
por: Yu, Jeong Il
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_usbelod8556vvuocvsec48nnjj